New results from the world's largest ovarian cancer screening study demonstrate that a strategy that starts with a simple blood test called CA-125 may result in fewer ovarian cancer deaths. That's because the CA-125-based strategy identifies more women with ovarian cancer in earlier stages.

While the study is a significant step forward for early detection, it may be years before ovarian cancer screening guidelines change....